50 results
8-K/A
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
10 Dec 20
Financial Statements and Exhibits
4:13pm
Effective January 1, 2019, the Company adopted Accounting Standards Codification (ASC) 842, Leases (ASC 842). This standard increases transparency
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
20 Oct 20
Results of Operations and Financial Condition
10:52am
programs Governance Diverse Board of Directors; all directors, aside from CEO, independent including the Chairman; transparency with stakeholders
20 … Clinical Pharmacy Specialist UCLA Ronald Reagan Medical Center Mrdavis@mednet.ucla.edu @Mattdavis138 55
Transparency Declaration No disclosures related
8-K
EX-2.1
rv7 jnikiq139mh
9 Aug 18
Entry into a Material Definitive Agreement
9:05am
8-K
EX-10.1
riru7wkqcsa1l3f
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.12
lqaxdev1 6t3
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.11
fxk7yuavyj893i51z
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.12
ykp9j6k9pxji1f
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.2
qfbo2dy
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.6
aa6zdtfgjpc865g
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.5
2mzij9mg4dfvpjf
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.3
zvo1d6lt71baigxe35j
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.4
j792i lv89ws6
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.7
m0sdlmzl
22 May 18
Entry into a Material Definitive Agreement
5:12pm